Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Chemodosimetry of Invivo Tumor Liposome/Drug Concentration using MRI. Edition No. 1

VDM Publishing House, May 2009, Pages: 220


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

The goal of this reseach was to demonstrate if MRI can be used to determine the Doxorubicin (DOX) concentration delivered in MnSO4 labled liposomes in an invivo tumor model. Using a temperature sensitive liposome formulation, it was found that MnSO4 release significantly increased the MRI signal. The degree of signal enhancment was measured and converted to DOX concentration. This MRI measured concentration was compared to direct histological measurements using fluorescence microscopy of identical regions of interest. There was a linear relationship with a slope and intercept that statistically include 1.0 and 0.0, suggesting that MRI can be used to quantify the distribution DOX delivered in thermal and non-thermally sensitive liposomes. This liposome contrast agent has potential for use with hyperthermia, by providing individualized monitoring of tissue drug concentration distribution during or after treatment. This would allow for: 1) modification of treatment variables to improve the uniformity of drug delivery and 2) provide a means to select patients most likely to benefit from this liposomal drug treatment.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds